Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancerJunghun Huh(CHA University), Hee Jung An(CHA University)British Journal of CancerJune 27, 201310.1038/bjc.2013.305Cited by 113SaveCiteExport RISWatch citationsRelated PapersEstablishment and Its Utility of a Patient-Derived Cell Xenografts (PDCX) Model with Cryopreserved Cancer Cells from Human Tumor|Cells|2025|1